Rossella Siligato, Guido Gembillo, Alfredo De Giorgi, Alessio Di Maria, Laura Maria Scichilone, Matteo Capone, Francesca Maria Vinci, Simone Nicoletti, Marta Bondanelli, Cristina Malaventura, Alda Storari, Domenico Santoro, Sara Dionisi, Fabio Fabbian
{"title":"Financial Toxicity and Kidney Disease in Children and Adults: A Scoping Review.","authors":"Rossella Siligato, Guido Gembillo, Alfredo De Giorgi, Alessio Di Maria, Laura Maria Scichilone, Matteo Capone, Francesca Maria Vinci, Simone Nicoletti, Marta Bondanelli, Cristina Malaventura, Alda Storari, Domenico Santoro, Sara Dionisi, Fabio Fabbian","doi":"10.2147/IJNRD.S485111","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Social determinants of health have been related with kidney diseases and their outcomes. Financial toxicity (FT) refers to the negative impact of health care costs on clinical conditions. This scoping review aimed to evaluate the literature linking FT with renal diseases.</p><p><strong>Patients and methods: </strong>We Included all studies analyzing FT and renal disease recorded in PubMed, Embase and Google Scholar between 2013 and 2023. The research question was formulated with reference to the acronym PCC (Problem, Concept and Contest). For each included study, we considered the study design, the population and main results from different populations with distinct renal conditions and the results were summarized in four tables.</p><p><strong>Results: </strong>Socioeconomic deprivation was the main cause of FT, and the majority of studies on the relationship between FT and chronic kidney disease (CKD) were conducted in the USA (4 studies evaluated the pediatric population and 6 studies included adults). Three studies reported the impact of FT on nephrolithiasis, and 3 studies analyzed the link between FT and renal tumors. The methods used for detecting FT differed and were based on consultations, questionnaires, expenditures and database records analysis. The COmprehensive Score for financial Toxicity (COST) questionnaire was used in 7 studies (43%), and the prevalence of FT was reported to be high in children and adults.</p><p><strong>Conclusion: </strong>Although the quality of the selected study is limited, due to different populations investigated and heterogeneity in detecting FT, the latter seems to be a frequent finding in people with renal disease. Health care professionals should recognize socioeconomic deprivation as the major cause of FT. Detecting FT could help in prioritizing patient-centered care in populations with renal diseases through the development of strategies aimed at improving care for people with kidney diseases.</p>","PeriodicalId":14181,"journal":{"name":"International Journal of Nephrology and Renovascular Disease","volume":"18 ","pages":"13-25"},"PeriodicalIF":2.1000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11770919/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Nephrology and Renovascular Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/IJNRD.S485111","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Social determinants of health have been related with kidney diseases and their outcomes. Financial toxicity (FT) refers to the negative impact of health care costs on clinical conditions. This scoping review aimed to evaluate the literature linking FT with renal diseases.
Patients and methods: We Included all studies analyzing FT and renal disease recorded in PubMed, Embase and Google Scholar between 2013 and 2023. The research question was formulated with reference to the acronym PCC (Problem, Concept and Contest). For each included study, we considered the study design, the population and main results from different populations with distinct renal conditions and the results were summarized in four tables.
Results: Socioeconomic deprivation was the main cause of FT, and the majority of studies on the relationship between FT and chronic kidney disease (CKD) were conducted in the USA (4 studies evaluated the pediatric population and 6 studies included adults). Three studies reported the impact of FT on nephrolithiasis, and 3 studies analyzed the link between FT and renal tumors. The methods used for detecting FT differed and were based on consultations, questionnaires, expenditures and database records analysis. The COmprehensive Score for financial Toxicity (COST) questionnaire was used in 7 studies (43%), and the prevalence of FT was reported to be high in children and adults.
Conclusion: Although the quality of the selected study is limited, due to different populations investigated and heterogeneity in detecting FT, the latter seems to be a frequent finding in people with renal disease. Health care professionals should recognize socioeconomic deprivation as the major cause of FT. Detecting FT could help in prioritizing patient-centered care in populations with renal diseases through the development of strategies aimed at improving care for people with kidney diseases.
目的:健康的社会决定因素与肾脏疾病及其结果有关。经济毒性(FT)是指医疗费用对临床状况的负面影响。本范围综述旨在评估将财务毒性与肾脏疾病相联系的文献:我们纳入了2013年至2023年期间PubMed、Embase和谷歌学术中所有分析FT与肾脏疾病的研究。研究问题的提出参考了缩写词 PCC(问题、概念和竞赛)。对于每项纳入的研究,我们都考虑了研究设计、研究人群以及来自不同肾病人群的主要结果,并将结果汇总在四个表格中:社会经济贫困是导致 FT 的主要原因,有关 FT 与慢性肾脏病(CKD)之间关系的研究大多在美国进行(4 项研究评估了儿童人群,6 项研究纳入了成年人)。3 项研究报告了 FT 对肾炎的影响,3 项研究分析了 FT 与肾肿瘤之间的联系。用于检测 FT 的方法各不相同,分别基于咨询、问卷调查、支出和数据库记录分析。7项研究(43%)使用了经济毒性综合评分(COST)问卷,据报道,儿童和成人的肾结石发病率较高:结论:尽管所选研究的质量有限,但由于调查的人群不同以及在检测财务毒性方面的异质性,后者似乎是肾病患者的一个常见发现。医护人员应认识到,社会经济贫困是导致FT的主要原因。通过制定旨在改善肾脏疾病患者护理的策略,检测 FT 有助于在肾脏疾病患者中优先考虑以患者为中心的护理。
期刊介绍:
International Journal of Nephrology and Renovascular Disease is an international, peer-reviewed, open-access journal focusing on the pathophysiology of the kidney and vascular supply. Epidemiology, screening, diagnosis, and treatment interventions are covered as well as basic science, biochemical and immunological studies. In particular, emphasis will be given to: -Chronic kidney disease- Complications of renovascular disease- Imaging techniques- Renal hypertension- Renal cancer- Treatment including pharmacological and transplantation- Dialysis and treatment of complications of dialysis and renal disease- Quality of Life- Patient satisfaction and preference- Health economic evaluations. The journal welcomes submitted papers covering original research, basic science, clinical studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports and extended reports. The main focus of the journal will be to publish research and clinical results in humans but preclinical, animal and in vitro studies will be published where they shed light on disease processes and potential new therapies and interventions.